Accuracy of sentinel node biopsy in breast cancer patients with a high prevalence of axillary metastases

Scandinavian Journal of Surgery

Volumn 98, Issue 1, 2009, Pages 30-33

  Moghimi, Mehrdad ^a,c   Ghoddosi, I ^a   Rahimabadi, A E ^a   Sheikhvatan, M ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c NONE   (Iran)

Author keywords

Accuracy; Axillary lymph node dissection; Breast cancer; Negative predictive value; Positive predictive value; Sentinel lymph node biopsy; Specificity; Staging

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; PREDICTION; PREVALENCE; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; AXILLA; BREAST TUMOR; CROSS-SECTIONAL STUDY; LYMPHADENECTOMY; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

AXILLA; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 67649103635     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690909800106     Document Type: Article

References (29)

1. Fisher ER, Anderson S, Redmond C, Fisher B: Pathologic findings from the National Surgical Adjuvant Breast Project Protocol B-06: 10 year pathological and clinical prognostic discriminants. Cancer 1993;71:2507-2514
2. Taylor KO: Morbidity associated with axillary surgery for breast cancer. ANZ J Surg 2004;74:314-317
3. Bass SS, Lyman GH, McCann CR et al: Lymphatic mapping and sentinel lymph node biopsy. Breast J 1999;5:288-295
4. Knauer M, Konstantiniuk P, Haid A et al: Multicentric Breast Cancer: A New Indication for Sentinel Node Biopsy A Multi-Institutional Validation Study. J Clin Oncol 2006;24:3374-3380
5. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-398
6. Schrenk P, Hatzl-Griesenhofer M, Shamiyeh A, Waynad W: Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 2001;77: 165-170
7. Travagli JP, Atallah D, Mathieu MC et al: Sentinel lymphadenectomy without systemic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis. Eur J Surg Oncol 2003;29:403-406
8. Haid A, Koberle-Wuhrer R, Knauer M et al: Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: A comparative evaluation. Breast Cancer Res Treat 2002;73:31-36
9. Baron RH, Fey JV, Borgen PI, Van Zee KJ: Eighteen sensations after breast cancer surgery: a two-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Oncol Nurs Forum 2004;13:691-698
10. Peintinger F, Reitsamer R, Stranzl H, Ralph G: Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 2003;89:648-652
11. Blanchard DK, Donohue JH, Reynolds C, Grant CS: Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003;138:482-488
12. Zavagno G, Carcoforo P, Franchini Z et al: Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients. Eur J Surg Oncol 2005;31:715-720
13. Liberman L: Pathologic analysis of sentinel lymph nodes in breast carcinoma. Cancer 2000;88:971-977
14. Tafra L, Lannin DR, Swanson MS et al: Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001;233:51-59
15. Haid A, Koeberle-Wuehrer R, Offner F et al: Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer. Chirurg 2003;74:657-664
16. Hsueh EC, Turner RR, Glass EC et al: Sentinel node biopsy in breast cancer. J Am Coll Surg 1999;189:207-213
17. Borgstein PJ, Meijer S, Pijpers R: Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997; 349:1668-1669
18. Cserni G, Amendoeira I, Apostolikas N et al: European working group for Breast Screening Pathology. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 2003;39:1654-1667
19. Cox CE, Pendas S, Cox JM et al: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645-651
20. Kim T, Giuliano AE, Lyman GH: Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 2006;106:4-16
21. Tanis PJ, Boom RP, Kops HS, et al: Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol 2001;8:222-226
22. Bedrosian I, reynolds C, Mick R, et al: Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 2000;88:2540-2545
23. Chung MH, Ye W, Giuliano AE: role for sentinel lymph node dissection in the management of large (> or = 5cm) invasive breast cancer. Ann Surg Oncol 2001;8:688-692
24. Bembenek A, Kettelhack C, Reuhl T et al: Sentinel" lymph node biopsy in breast carcinoma. Current experiences. Zentralbl Chir 2000; 125:817-821
25. Moran CJ, Kell MR, Flanagan FL et al: role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients. Am J Surg 2007;194:172-175
26. Coombs N, Chen W, Taylor R, Boyages J: A decision tool for predicting sentinel node accuracy from breast tumor size and grade. Breast J 2007;13:593-598
27. Olson JA Jr, Fey J, Winawer J et al: Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer. J Am Coll Surg 2000;191:593-599
28. Krontiras H, Bland KI: When is sentinel node biopsy for breast cancer contraindicated? Surg Oncol 2003;12:207-210
29. Mansel RE, Fallowfield L, Kissin M et al: randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. J Natl Cancer Inst 2006;98:599-609